M Palatnik Selected Research

fucose-binding lectin

4/2001	Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani.
12/2000	A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (São Gonçalo do Amaranto, RN).
1/2000	Short report: occurrence of Leishmania donovani DNA in donated blood from seroreactive Brazilian blood donors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Palatnik Research Topics

Disease

9	Visceral Leishmaniasis (Kala Azar) 01/2010 - 01/2000
3	Infections 08/2007 - 06/2004
2	Hypersensitivity (Allergy) 08/2007 - 04/2001
1	Latent Infection 01/2010
1	Hemolysis 05/2006
1	Body Weight (Weight, Body) 05/2006
1	Leishmaniasis 09/2002

Drug/Important Bio-Agent (IBA)

6	SaponinsIBA 01/2010 - 09/2002
5	VaccinesIBA 01/2010 - 12/2000
5	Fluorometholone (FML)FDA Link 05/2006 - 01/2000
3	AntigensIBA 05/2006 - 04/2001
3	fucose-binding lectinIBA 04/2001 - 01/2000
2	Immunoglobulin G (IgG)IBA 06/2004 - 04/2001
1	Monoterpenes (Monoterpenoids)IBA 01/2007
1	TriterpenesIBA 01/2007
1	Glucose (Dextrose)FDA LinkGeneric 05/2006
1	DEAE-CelluloseIBA 05/2006
1	QuercetinIBA 05/2006
1	Rutin (Rutoside)IBA 05/2006
1	Sucrose (Saccharose)IBA 05/2006
1	saponin QA-21V1 (QS21)IBA 05/2006
1	anti-IgMIBA 06/2004
1	SapogeninsIBA 06/2004
1	AldehydesIBA 06/2004
1	DNA (Deoxyribonucleic Acid)IBA 09/2002
1	AntibodiesIBA 04/2001
1	Glycoproteins (Glycoprotein)IBA 04/2001

Therapy/Procedure

2	Immunotherapy 01/2010 - 08/2007
1	Drug Therapy (Chemotherapy) 01/2010
1	Blood Transfusion (Blood Transfusions) 01/2000